EXPERIENCE MATTERS
Accelerate your next breakthrough on the leading Al-powered platform.
See how Experience Matters to our customers
Learn How the Latest Innovations Help Solve Your Most Pressing Challenges
Understand how our customers are implementing advanced technology to meet goals head-on.
The Heart of Innovative Clinical Trial Technology is at Your Fingertips
Get a Secure and Scalable Clinical Research Platform with the Interoperability You Need.
Whether you need us for end-to-end clinical research or just one portion of your journey, our cloud-based platform gives you the security, scalability, and flexibility you need.
- Open APIs for seamless data sharing
- 99.9% uptime
- Unmatched stability so every role on the team can access secure, up-to-date information when and where they need it
18 of the Top 25 Medical Device Companies Trust Medidata to Get to Market Faster.
From recruiting patients to clearing regulatory, we can help you get your medical device or diagnostic tool to market faster.
- Leverage continuous digital innovation backed by devoted Medical Device and Diagnostic experts that understand your specific study needs.
- The only end-to-end platform connecting data across the entire lifecycle of your device or diagnostic tool—no data silos
- 800+ medical device trials completed, across 21,000+ sites, with over 600,000 patients and 45 billion data points
AI-powered Trial Design Mitigates Risks for Faster Breakthroughs.
Our AI-powered technology draws on the industry’s largest clinical trial database (33K+ trials and counting) to hone your decision-making:
- Know more with scenario modeling based on your parameters
- Find the right patients with sharper recruitment strategies that draw on our 10M+ global patient datasets
- Close data gaps with relevant cross-trial datasets
- Mitigate risk better to avoid delays
Medidata Integrates all your Data with AI to Accelerate Timelines.
Clinical Data Studio gives you the most complete data management and quality experience – with AI-powered insights across all your data sources.
- Accelerate data review with embedded AI and workflow automation
- Mitigate and reduce risk with predictive analytics
- Explore and combine data with low/no code transformation
- Unlock deeper insights with comprehensive visualizations
Achieve Mid-study Changes without Disruptions.
Adaptive clinical trials are a fact of life now. Nobody handles mid-study changes as seamlessly as Medidata.
- Over 33,000+ mid-study changes a year
- Changes in hours, not months with robust technology
- No disruption to study, sites, or patients; no data is moved
- Mid-study changes for the largest and most complex trials, including “rescues” where a competitor was unable to adapt
Trust 25+ years of Experience to Meet Regulatory Success.
Governing bodies have different guidelines. Better anticipate all the clinical trial data you’ll need to achieve regulatory success.
- Learn from the extensive experience of working directly with regulators and understanding regulatory guidance
- Ensure business compliance in a secure, stable, and scalable cloud platform used by thousands of customers
- Access an innovative, global ecosystem and presence with regulatory bodies, including FDA, MHRA, DKMA, UK HRA, UK NIHR, ACRO, and more
Analyst-backed Perspectives Meet Leading Expertise
Join us at the forefront of harnessing artificial intelligence (AI) and decentralized clinical trial (DCT) technologies to enhance clinical development experiences.
Our Experience, Your Advantage
Our 25+ years of worldwide collaboration with customers, patients, and partners lets us deliver unmatched results to help propel human health forward.
Clinical Trials
Thousands of studies in 140+ countries have been conducted on the Medidata platform.
Patients
Over 10 million patient participants across Medidata trials have impacted clinical research and touched countless lives.
Customers
Medidata studies, patients, and data are involved in nearly 23% of company-initiated trial starts globally.
FDA-approved novel drugs
Medidata was involved in 65% of 2023 FDA novel drug approvals and 60% since 2015*.
*Excludes vaccines and biologics